MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea
· Delayed Price · Currency is KRW 27,500
+400 (1.48%)
Apr 29, 2026, 12:20 PM KST
MEDIPOST Revenue
In the year 2025, MEDIPOST had annual revenue of 73.66B KRW with 4.25% growth. MEDIPOST had revenue of 17.91B in the quarter ending December 31, 2025, with 0.40% growth.
Revenue
73.66B
Revenue Growth
+4.25%
P/S Ratio
14.38
Revenue / Employee
228.75M
Employees
322
Market Cap
1,059.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.66B | 3.00B | 4.25% |
| Dec 31, 2024 | 70.66B | 2.01B | 2.93% |
| Dec 31, 2023 | 68.64B | 4.44B | 6.92% |
| Dec 31, 2022 | 64.20B | 9.34B | 17.03% |
| Dec 31, 2021 | 54.86B | 6.23B | 12.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GI Innovation | 5.84B |
| Onconic Therapeutics | 53.39B |
| Pharmicell | 23.94B |
| Medy-Tox | 247.29B |
| Chabiotech | 1,268.25B |
| GC Corp. | 2,451.48B |
| Orum Therapeutics | 23.56M |
| SillaJen | 9.23B |